For partners For investors Careers Support Documentation About us
For investors

The system of record for life-sciences validation.

Qualitum builds private, audited agentic AI for the most regulated work in pharma - computer system validation, quality, and compliance. A short overview for prospective investors is below.

The thesis

High-level, in three lines.

The market. Every regulated therapy ships on a mountain of validation evidence. It is authored by hand, in documents, by some of the most expensive people in the building - and it is the work least touched by software.

The product. Qualitum runs agentic AI inside the customer’s own tenant to author, execute, and defend the full validation lifecycle under GAMP 5, EudraLex Annex 11, and 21 CFR Part 11 - with a tamper-evident audit trail on every action.

The wedge. Private deployment and zero data egress is what unlocks the regulated buyer. It is also the moat: switching cost compounds with every validated artifact that lives in the system.

Category

A new system of record

Not a copilot bolted onto Word. Validation evidence becomes live, queryable, continuously maintained data inside the customer perimeter.

Defensibility

Regulated-grade by design

Private tenant, customer-managed keys, zero egress, full audit trail. The compliance posture that wins the buyer is hard to replicate and harder to displace.

Expansion

One platform, many agents

Validate is live; Operate, Risk, and Investigate extend the same architecture across quality and compliance. Land in validation, expand across the lifecycle.

Interested in investing?

We share our data room and a deeper briefing with relevant funds under NDA. Tell us a little about your firm and we’ll be in touch.

Prefer email? Reach the founders directly.

investors@qualitum.ai